Find a Doctor Subscribe free
📖 1 min read
Multiple Sclerosis

Disease-Modifying Therapies for MS: A Clinical Comparison

Sa
Medically Reviewed by Dr. Sarah Jenkins, MD, FACP ⭐ Board-Certified Clinical Specialist
Specialty: Internal Medicine · Institution: Stanford University School of Medicine
Medical Council License #IM-4091A

Written by DrManthan Editorial Team (Medical Writer)
⚠️ Medical Disclaimer: This article is for informational purposes only. Always consult a qualified doctor or healthcare specialist before making medical decisions or starting any treatment plan.
    Close-up of clinical medication packaging and water glass
    📷 Close-up of clinical medication packaging and water glass

    Selecting the Safest and Most Effective DMT for MS

    Disease-Modifying Therapies (DMTs) are the cornerstone of managing Relapsing-Remitting Multiple Sclerosis (RRMS). They target the immune system to reduce neurological inflammation.

    Main Types of DMTs

    • Injectable Medications: Interferon beta and Glatiramer acetate. Classic therapies with solid, long-term safety profiles.
    • Oral Medications: Fingolimod, Teriflunomide, and Dimethyl fumarate. Convenient capsules that regulate immune cell populations.
    • Infusion Therapies: Natalizumab and Ocrelizumab. Highly effective monoclonal antibodies that block immune cells from entering the brain.

    Collaborative decisions: Work closely with your neurologist to balance therapeutic efficacy with periodic safety monitoring.

    📚 Clinical & Academic Sources

    Dr. Manthan applies a strict sourcing strategy, linking exclusively to peer-reviewed journals, academic boards, and trusted public health authorities:

    DM

    About DrManthan Editorial Team

    DrManthan Editorial Team is a leading team of clinicians and digital health pioneers, combining clinical research with evidence-based medicine to empower healthy communities across India.

    Share this evidence-based article